Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: Results from the scleroderma lung study-Reference-Cited by-同舟云学术

Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: Results from the scleroderma lung study

Published:2005 Issue:2 Volume:52 Page:592-600
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Khanna Dinesh,Clements Philip J.,Furst Daniel E.,Chon Yun,Elashoff Robert,Roth Michael D.,Sterz Mildred G.,Chung Joannie,FitzGerald John D.,Seibold James R.,Varga John,Theodore Arthur,Wigley Fredrick M.,Silver Richard M.,Steen Virginia D.,Mayes Maureen D.,Connolly M. Kari,Fessler Barri J.,Rothfield Naomi F.,Mubarak Kamal,Molitor Jerry,Tashkin Donald P.,

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference21 articles.

1. Systemic sclerosis (scleroderma): clinical aspects. In: editor. Arthritis and allied conditions: a textbook of rheumatology. 13th ed. Baltimore: Williams & Wilkins; 1997. p. 1433-64.

2. Severe restrictive lung disease in systemic sclerosis

3. The MOS 36-ltem Short-Form Health Survey (SF-36)

4. The value of the health assessment questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time

5. The Measurement of Dyspnea

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heterogeneity of determining disease severity, clinical course and outcomes in systemic sclerosis-associated interstitial lung disease: a systematic literature review;RMD Open;2023-11

2. The long-term course of the Health Assessment Questionnaire in patients with systemic sclerosis;Journal of Scleroderma and Related Disorders;2023-06-21

3. Impact of lung function and baseline clinical characteristics on patient-reported outcome measures in systemic sclerosis-associated interstitial lung disease;Rheumatology;2022-05-31

4. Quantitative evaluation of disease severity in connective tissue disease-associated interstitial lung disease by dual-energy computed tomography;Respiratory Research;2022-03-05

5. Dyspnoea and cough in patients with systemic sclerosis–associated interstitial lung disease in the SENSCIS trial;Rheumatology;2022-02-12